Natera registered 68,023 shares for potential resale by unnamed, non-affiliated selling stockholders. The total includes 45,533 closing shares issued on or about November 10, 2026 and an estimated 22,490 additional shares; Natera receives no proceeds.
NTRA · Natera, Inc. · Documents
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
Natera targets $6 billion in revenue by 2029, using $14.50 Signatera ASP versus $12.90 today as an illustrative path. Solomon became CEO immediately, with operating and commercial structures unchanged.
Natera CEO Solomon Moshkevich targets $6 billion in revenue for 2029; Signatera is expected to generate a little over a billion this year, with the fine study readout expected in the back half of next year.
Natera says Solomon will succeed Steve as CEO, raising full-year 2026 revenue guidance to $3 billion $5 million-$3 billion $35 million and targeting $6 billion in 2029.
Natera reported that total revenues increased $201.8 million, or 34.1%, in the three months ended September 30, 2026, while net loss narrowed 31.6%. For the nine months, revenue was $2,243.4 million and net loss was $212.0 million.
Natera reported third quarter 2026 total revenues of $794.0 million, up 34.1% from $592.2 million, with gross margin of 64.7% and a net loss of $59.9 million, or ($0.42) per diluted share. It raised 2026 revenue guidance to $3.005 billion - $3.035 billion and processed approximately 1,093,100 tests.